Primary record
3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-; 6-Fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; A 56620; PD 121960; Sarafloxacin
- 库存
- 7,840 克
- 纯度
- 98.1 %
- CAS
- 98105-99-8
化合物标识与属性
- CAS
- 98105-99-8
- PubChem CID
- 56208
- SMILES
- C1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F
- Canonical SMILES
- O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O
名称与同义词
- Sarafloxacin
- Sarafloxacine
- Sarafloxacino
- Sarafloxacinum
- 98105-99-8
- Difloxacine
- Difloxacino
- Difloxacinum
- null
- saraflozacin
- Quinolone der.
- Saraflox
- sarafloxacinbase
- Difloxacine [French]
- Difloxacinum [Latin]
- Difloxacino [Spanish]
- Sarafloxacin [INN:BAN]
- Abbott 57135
- Sarafloxacin (INN)
- Difloxacinum (Latin)
- Sarafloxacine [INN-French]
- Sarafloxacinum [INN-Latin]
- RC3WJ907XY
- Sarafloxacin protomer I
- Sarafloxacino [INN-Spanish]
- UNII-RC3WJ907XY
- Sarafloxacin protomer II
- 1-FPFPOC
- RefChem:181311
- Spectrum2_000036
- Spectrum3_001953
- ABBOTT-57135
- C20H17F2N3O3
- SARAFLOXACIN [MI]
- 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
- DTXSID8048494
- SARAFLOXACIN [INN]
- SARAFLOXACIN HYDROCHLORIDE
- HSDB 7035
- SARAFLOXACIN [HSDB]
- AC1L1KL9
- AC1Q4NT6
- CCRIS 8500
- XBHBWNFJWIASRO-UHFFFAOYSA-N
- BSPBio_003553
- DTXCID4028468
- MLS006011798
- CHEMBL37858
- SCHEMBL311593
- SPBio_000131
- MFCD00865974
- orb1306536
- CHEBI:94493
- CTK3I6728
- GTPL10857
- KBio3_002868
- KS-00002WVW
- GLXC-07129
- HMS2090N09
- HMS3715K18
- ZINC538330
- ALBB-028536
- CID56208
- RKL10086
- A-56620
- Sarafloxacin hydrochloride trihydrate
- Tox21_303838
- BBL010397
- Sarafloxacin, 98% - 10MG 10mg
- STK713346
- AKOS004938890
- C20-H17-F2-N3-O3
- CCG-221098
- DB11491
- FS38236
- KS-5005
- abbott 56620 pound masculinea-56620
- NCGC00177995-01
- NCGC00177995-03
- NCGC00177995-04
- NCGC00356946-01
- AC-12861
- AJ-23389
- AN-25173
- PD121960
- SC-54199
- SMR001550490
- SBI-0206753.P001
- 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
- AB1009571
- CAS-98105-99-8
- DB-057710
- J134.054I
- LS-184404
- PD 121960
- TR-030288
- 3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
- CS-0013790
- FT-0630998
- NS00000677
- 6-Fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
- A56620
- D08506
- E73929
- AB00923780-04
- AB00923780_06
- AB00923780_07
- 105S998
- A 56620
- A 57135
- A845810
- A858584
- SR-05000002002
- Q7421984
- SR-05000002002-2
- BRD-K08525451-003-03-7
- BRD-K08525451-003-05-2
- BRD-K08525451-003-06-0
- 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
- Sarafloxacin, Sarafloxacin Hydrochloride, Sarafloxacin HCl
- 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-piperazino-3-quinolinecarboxylic acid
- 3-quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride
- 1-p-fluoro-phenyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid
- 6-fluoranyl-1-(4-fluorophenyl)-4-oxidanylidene-7-piperazin-1-yl-quinoline-3-carboxylic acid
- 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
- 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
- 6-fluoro-1-(4-fluorophenyl)-7-piperazinyl-1,4-dihydro-4-quinolone-3-carboxylic acid
- DIFLOXACIN HYDROCHLORIDE TRIHYDRATE FOR VETERINARY USE IMPURITY B [EP IMPURITY]
- 1,4-Dihydro-6-fluoro-7-(piperazin-1-yl)-1-(4-fluorophenyl)-4-oxoquinoline-3-carboxylic acid
- 1,4-dihydro-6-fluoro-7-(piperazine-1-yl)-1-(4-fluorophenyl)-4-oxoquinoline-3-carboxylic acid
- 1,8-Naphthyridine-3-carboxylic acid,6-fluoro-1,4-dihydro-1-(4-hydroxy-3-methylphenyl)-7-(4-methyl-1-piperazinyl)-4-oxo-
- 1,8-Naphthyridine-3-carboxylic acid,7-(4-acetyl-1-piperazinyl)-6-fluoro-1,4-dihydro-1-(4-methylphenyl)-4-oxo-, ethyl ester
- 1-(2,4-difluorophenyl)-6-fluoro-7-(4-(methylamino)piperidin-1-yl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 1-(4-cyanophenyl)-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 100490-21-9
- 100490-25-3
- 100490-31-1
- 100490-34-4
- 100490-58-2
- 100490-59-3
- 100490-66-2
- 100490-96-8
- 100490-99-1
- 100491-40-5
- 100491-42-7
- 100491-49-4
- 100491-75-6
- 3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-; 6-Fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; A 56620; PD 121960; Sarafloxacin
- 3-Quinolinecarboxylicacid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
- 6-floro-1-(4-fluorophenyl)-1 pound not4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinojinecarboxylic acid
- 6-Fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, 9CI
- 6-Fluoro-1-(4-fluorophenyl)-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid
- 6-fluoro-1-(4-hydroxy-2-methylphenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 6-FLUORO-1-(P-FLUOROPHENYL)-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)-3-QUINOLINECARBOXYLIC ACID
- 6-fluoro-4-oxo-7-(piperazin-1-yl)-1-(4-(trifluoromethyl)phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 7-(3,5-dimethylpiperazin-1-yl)-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid compound with methanesulfonic acid (1:1)
- 7-Chloro-6-fluoro-1-(4-methoxy-phenyl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid ethyl ester
- 91296-87-6
- ethyl (E)-2-(2,6-dichloro-5-fluoropyridine-3-carbonyl)-3-(2,4-difluoroanilino)prop-2-enoate
- ethyl 7-chloro-1-(4-cyanophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate
- ethyl 7-chloro-6-fluoro-1-(4-methoxy-2-methylphenyl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate